Eric Schmid advises life sciences and technology companies over the course of their full life cycle, from formation to exit. He counsels these companies on both general corporate and strategic matters, including venture financings and exits through private sale or public listing. Eric also represents venture capital, growth and private equity funds on investment transactions and acquisitions in the life sciences and technology sectors. 

Download full bio 


  • Vendr Achieves Unicorn Status With $150 Million Series B 

  • Vendr Closes $60 million Series A 

  • Tectonic Therapeutic Closes $80 Million Series A Financing 

  • Thriveworks Closes Series B Financing 


  • Boston College Law School
    JD, magna cum laude, Order of the Coif, 2020

  • Wake Forest University
    BA, Psychology

Admissions & Credentials